Key result
Autopsy and PCR analysis of 8 elderly patients with fatal COVID-19 revealed active lymphocytic viral myocarditis, coronaritis, and SARS-CoV-2 RNA in the myocardium in 100% of cases.
Why the study?
Despite reported cardiac injury in patients with coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remained not fully clear.
Observational (n=8)
Yes
This autopsy study provides direct morphological, immunohistochemical, and PCR evidence of true viral lymphocytic myocarditis and coronaritis in patients with fatal COVID-19.
Suggests myocarditis may contribute to fatal COVID-19; hypothesis-generating and should not yet change practice.
BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in patients with severe coronavirus infection (COVID-19). METHODS: Autopsy data of eight elderly patients (75.6 ± 7.4 years), four male and four female, with severe new coronavirus infection were studied. The lifetime diagnosis of COVID-19 is based on a positive result of the PCR study. The inclusion criterion was the presence of morphological signs of myocarditis according to the Dallas criteria. A standard histological examination included staining by hematoxylin and eosin, toluidin blue and Van Gieson. An immunohistochemical study was performed using antibodies to CD3, CD 68, CD20, perforin, toll-like receptor (TLR) types 4 and 9. PCR in real-time was performed to determine the viral RNA in the myocardium. RESULTS: All patients had severe bilateral viral pneumonia. In all cases, myocarditis was not clinically diagnosed. Morphological examination of the heart found signs of active lymphocytic myocarditis. PCR identified the SARS-Cov2 RNA in all cases. There were also signs of destructive coronaritis in all cases, thrombovasculitis, lymphocytic pericarditis (in 3 cases) and endocarditis (in 2 cases). The absence of neutrophils confirms the aseptic nature of inflammation. An immunohistochemical study showed the CD3-positive T lymphocytes in the infiltrates. Increased expression of TLR type 4 and less 9 was also detected. CONCLUSION: Morphological and immunohistochemical evidence of myocarditis in COVID-19 was presented. Lymphocytic infiltrations and positive PCR confirm the viral nature of inflammation. Myocarditis in COVID-19 is also characterized by coronaritis with microvascular thrombosis and associated with lymphocytic endo- and pericarditis.
No takes yet. Share an insight, caveat, or question.
Коган et al. (2022) conducted an observational in Fatal COVID-19 (n=8). SARS-CoV-2 infection was evaluated on Presence of SARS-CoV-2 RNA and morphological signs of myocarditis. Autopsy and PCR analysis of 8 elderly patients with fatal COVID-19 revealed active lymphocytic viral myocarditis, coronaritis, and SARS-CoV-2 RNA in the myocardium in 100% of cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: